Atara Biotherapeutics, Inc. (ATRA)
9.76
+0.23
(+2.41%)
USD |
NASDAQ |
Sep 04, 16:00
10.34
+0.58
(+5.94%)
After-Hours: 20:00
Atara Biotherapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 501.85 |
| September 28, 2023 | 518.80 |
| September 27, 2023 | 515.41 |
| September 26, 2023 | 532.37 |
| September 25, 2023 | 552.71 |
| September 22, 2023 | 606.96 |
| September 21, 2023 | 603.57 |
| September 20, 2023 | 596.79 |
| September 19, 2023 | 535.76 |
| September 18, 2023 | 528.97 |
| September 15, 2023 | 518.80 |
| September 14, 2023 | 518.80 |
| September 13, 2023 | 501.85 |
| September 12, 2023 | 528.97 |
| September 11, 2023 | 569.67 |
| September 08, 2023 | 518.80 |
| September 07, 2023 | 522.19 |
| September 06, 2023 | 532.37 |
| September 05, 2023 | 512.02 |
| September 01, 2023 | 525.58 |
| August 31, 2023 | 495.07 |
| August 30, 2023 | 495.07 |
| August 29, 2023 | 512.02 |
| August 28, 2023 | 515.41 |
| August 25, 2023 | 481.50 |
| Date | Value |
|---|---|
| August 24, 2023 | 508.63 |
| August 23, 2023 | 512.02 |
| August 22, 2023 | 495.07 |
| August 21, 2023 | 478.11 |
| August 18, 2023 | 505.24 |
| August 17, 2023 | 542.54 |
| August 16, 2023 | 573.06 |
| August 15, 2023 | 623.92 |
| August 14, 2023 | 668.00 |
| August 11, 2023 | 708.69 |
| August 10, 2023 | 739.21 |
| August 09, 2023 | 637.48 |
| August 08, 2023 | 769.73 |
| August 07, 2023 | 762.94 |
| August 04, 2023 | 779.90 |
| August 03, 2023 | 783.29 |
| August 02, 2023 | 712.08 |
| August 01, 2023 | 729.04 |
| July 31, 2023 | 749.38 |
| July 28, 2023 | 698.52 |
| July 27, 2023 | 606.96 |
| July 26, 2023 | 661.22 |
| July 25, 2023 | 651.05 |
| July 24, 2023 | 691.74 |
| July 21, 2023 | 712.08 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.691 |
| Alnylam Pharmaceuticals, Inc. | 26.28 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.558 |
Price to Book Value Related Metrics
| PS Ratio | 19.70 |
| PEG Ratio | -0.0305 |
| Price | 9.76 |
| Earnings Yield | -14.33% |
| Market Cap | 92.16M |
| PEGY Ratio | -0.0305 |